News about Manufacturing

Lilly Announces USD 3.5 Billion Injectable Drug and Device Manufacturing Facility in Pennsylvania

Eli Lilly and Company has announced plans to invest USD 3.5 billion to build a new injectable drug and device manufacturing facility in the Lehigh Valley region of Pennsylvania, marking one of the largest life sciences investments in the state’s history.

Manufacturing | 31/01/2026 | By Darshana |  258

Cellares Moves Cell Therapy Manufacturing from Platform to Patients

The cell and gene therapy (CGT) sector is entering a phase of more disciplined and sustainable growth after years of volatility, according to industry leaders speaking at the 2026 Biotech Showcase in San Francisco.

Manufacturing | 29/01/2026 | By Darshana |  269

Siegfried Expands U.S. Manufacturing Capacity with Acquisition of Two Facilities

Siegfried, the Switzerland-based contract development and manufacturing organisation (CDMO), is expanding its manufacturing presence in the United States through the acquisition of two pharmaceutical production facilities.

Manufacturing | 28/01/2026 | By Darshana |  728

Naprod Life Sciences Secures ANVISA GMP Renewal for Tarapur Facility

Naprod Life Sciences has received renewal of its Good Manufacturing Practice (GMP) certification from Brazil’s health regulator, ANVISA, for its Tarapur manufacturing facility in Maharashtra.

Manufacturing | 27/01/2026 | By Darshana |  221

SK bioscience, MSD and Hilleman Advance Ebola Vaccine with CEPI Funding

he collaboration will receive up to USD 30 million in CEPI funding to support development of MSD’s Zaire ebolavirus vaccine, with a focus on improving manufacturing efficiency, enhancing thermostability and expanding affordable vaccine access in low- and middle-income countries.

Manufacturing | 23/01/2026 | By News Bureau |  219

India Cuts Review Period for Clinical Trial Drug Manufacturing to 45 Days

The central government has reduced the approval timeline for applications to manufacture drugs meant for clinical trials, a move aimed at accelerating clinical research and drug development in India.

Manufacturing | 22/01/2026 | By Darshana |  572

Agno Pharma Acquires Actylis's CDMO Manufacturing Asset

Agno Pharma has acquired Actylis’s CDMO manufacturing asset, the legacy Cascade Chemistry business based in Eugene, Oregon, strengthening Agno’s U. cGMP API development and manufacturing capabilities.

Manufacturing | 19/01/2026 | By News Bureau |  257

Serum Institute to Produce 100,000 Doses of Oxford Rift Valley Fever Vaccine

Serum Institute of India will produce up to 100,000 doses of an investigational Rift Valley fever vaccine developed by the University of Oxford, as the viral disease continues to affect parts of West Africa. The doses may be used for testing and future outbreak response, under an agreement supported by CEPI.

Manufacturing | 17/01/2026 | By News Bureau |  180

WuXi Biologics Introduces PatroLab to Enable Real-Time, Predictive Biomanufacturing

WuXi Biologics, a global contract research, development and manufacturing organization (CRDMO), has launched PatroLab, a next-generation digital twin platform aimed at reshaping bioprocess development and biologics manufacturing.

Manufacturing | 14/01/2026 | By Darshana |  581

AbbVie Secures Global Manufacturing and Commercialization Rights to RemeGen's Bispecific Cancer Antibody

AbbVie and RemeGen, a China-based innovative biopharmaceutical company, have entered into an exclusive licensing agreement covering the development, manufacturing, and commercialization of RC148, a novel investigational PD-1/VEGF-targeted bispecific antibody for the treatment of advanced solid tumours.

Manufacturing | 13/01/2026 | By Darshana |  193